Similar articles for PMID: 11138684

Year	Number of Results
1996	1
1998	5
1999	4
2000	8
2001	4
2002	7
2003	3
2004	2
2007	3
2012	1
2013	1
2014	1
2015	2
2016	1
2024	0

1

FDG PET in thyroid cancer: thyroxine or not?

Grünwald F, Biersack HJ. Grünwald F, et al. J Nucl Med. 2000 Dec;41(12):1996-8. J Nucl Med. 2000. PMID: 11138684 Free article. No abstract available.

2

Influence of thyroid-stimulating hormone levels on uptake of FDG in recurrent and metastatic differentiated thyroid carcinoma.

Moog F, Linke R, Manthey N, Tiling R, Knesewitsch P, Tatsch K, Hahn K. Moog F, et al. J Nucl Med. 2000 Dec;41(12):1989-95. J Nucl Med. 2000. PMID: 11138683 Free article.

3

Clinical usefulness of FDG PET in differentiated thyroid cancer.

Macapinlac HA. Macapinlac HA. J Nucl Med. 2001 Jan;42(1):77-8. J Nucl Med. 2001. PMID: 11197984 Free article. No abstract available.

4

Changing paradigms in the follow-up of patients with differentiated thyroid cancer: an alternative to [18F]fluorodeoxyglucose positron emission tomographic scanning.

Mazzaferri EL. Mazzaferri EL. Endocr Pract. 2003 Jul-Aug;9(4):324-6. doi: 10.4158/EP.9.4.324. Endocr Pract. 2003. PMID: 14561580 No abstract available.

5

Usefulness of 18F-FDG PET/CT in thyroid carcinoma.

Muros de Fuentes MA, Mitjavila Casanovas M, Estorch Cabrera M, Lecumberri Santamaria B, Navarro González E. Muros de Fuentes MA, et al. Rev Esp Med Nucl Imagen Mol. 2016 May-Jun;35(3):186-92. doi: 10.1016/j.remn.2016.01.006. Epub 2016 Mar 2. Rev Esp Med Nucl Imagen Mol. 2016. PMID: 26944558 Review. English, Spanish. No abstract available.

6

Increased F-18 fluorodeoxyglucose accumulation in a benign neurofibroma--a pitfall in a patient with thyroid cancer: a case report.

Gabriel M, Erler H, Donnemiller E, Riccabona G. Gabriel M, et al. Nuklearmedizin. 2002 Apr;41(2):N14-5. Nuklearmedizin. 2002. PMID: 11989305 No abstract available.

7

Role of FDG PET in metastatic thyroid cancer.

Wong CO, Dworkin HJ. Wong CO, et al. J Nucl Med. 1999 Jun;40(6):993-4. J Nucl Med. 1999. PMID: 10452316 Free article. No abstract available.

8

F-18 FDG PET/CT in the management of thyroid cancer.

Iagaru A, Kalinyak JE, McDougall IR. Iagaru A, et al. Clin Nucl Med. 2007 Sep;32(9):690-5. doi: 10.1097/RLU.0b013e318125037a. Clin Nucl Med. 2007. PMID: 17710020

9

[Standards, Options and Recommendations for the use of PET-FDG in cancerology. Results in cancer of the thyroid].

Bourguet P; Groupe de Travail SOR. Bourguet P, et al. Bull Cancer. 2003 Feb;90 Spec No:S105-9. Bull Cancer. 2003. PMID: 12739343 Review. French. No abstract available.

10

[F-18-FDG PET in autonomous goiter].

Börner AR, Voth E, Wienhard K, Wagner R, Schicha H. Börner AR, et al. Nuklearmedizin. 1999;38(1):1-6. Nuklearmedizin. 1999. PMID: 9987775 German.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

41 results

Results by year